Astellas US LLC v. Curia Missouri Inc.
1:22-cv-00199
Overview
Parties
Defendant
Curia Global, Inc. Operating Company
Represented By
4 Attorneys ListedGibbons P.C.
300 Delaware Avenue, Ste 1015
Gibbons P.C.
300 Delaware Avenue, Suite 1050
Curia Missouri Inc. Operating Company
Represented By
5 Attorneys ListedGibbons P.C.
300 Delaware Avenue, Ste 1015
Gibbons P.C.
300 Delaware Avenue, Suite 1050
Plaintiff
Gilead Sciences, Inc. Operating Company
Represented By
7 Attorneys ListedCooley LLP
10265 Science Center Drive, San Diego, CA 92121
Fish & Richardson, P.C.
222 Delaware Avenue, 17th Floor, P.O. Box 1114
Fish & Richardson, P.C.
222 Delaware Avenue, 17th Floor, P.O. Box 1114
Fish & Richardson P.C.
60 South Sixth Street, # 3200, Minneapolis, MN 55402
Fish & Richardson, P.C.
222 Delaware Avenue, 17th Floor, P.O. Box 1114
Astellas Pharma US, Inc. Operating Company
Represented By
5 Attorneys ListedCooley LLP
10265 Science Center Drive, San Diego, CA 92121
Fish & Richardson, P.C.
222 Delaware Avenue, 17th Floor, P.O. Box 1114
Fish & Richardson, P.C.
222 Delaware Avenue, 17th Floor, P.O. Box 1114
Fish & Richardson P.C.
60 South Sixth Street, # 3200, Minneapolis, MN 55402
Fish & Richardson, P.C.
222 Delaware Avenue, 17th Floor, P.O. Box 1114
Astellas US LLC Operating Company
Represented By
5 Attorneys ListedCooley LLP
10265 Science Center Drive, San Diego, CA 92121
Fish & Richardson, P.C.
222 Delaware Avenue, 17th Floor, P.O. Box 1114
Fish & Richardson, P.C.
222 Delaware Avenue, 17th Floor, P.O. Box 1114
Fish & Richardson P.C.
60 South Sixth Street, # 3200, Minneapolis, MN 55402
Fish & Richardson, P.C.
222 Delaware Avenue, 17th Floor, P.O. Box 1114
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 21 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | Asserted | US Continuation / Sibling | View Official Patent → |
| 🌐 PCT International (WIPO) | PCT World Application | View Official Patent → | |
| 🇨🇦 Canada | Canada Counterpart | View Official Patent → | |
| 🇨🇦 Canada | Canada Counterpart | View Official Patent → | |
| 🇩🇪 Germany | Germany Counterpart | View Official Patent → | |
| 🇩🇪 Germany | Germany Counterpart | View Official Patent → | |
| 🇪🇺 European Patent Office (UPC States) | European Counterpart (EP) | View Official Patent → | |
| 🇪🇺 European Patent Office (UPC States) | European Counterpart (EP) | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇨🇳 China | China Counterpart | View Official Patent → | |
| 🇯🇵 Japan | Japan Counterpart | View Official Patent → | |
| 🇯🇵 Japan | Japan Counterpart | View Official Patent → | |
| 🇰🇷 South Korea | South Korea Counterpart | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There are 3 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US6403567
N-pyrazole A2A adenosine receptor agonists
|
Filed: 1999-06-22
Issued: 2002-06-11
|
Expired (Term Ended)
+1024d PTA
Expires: 2022-04-11
|
|
|
US8524883
Monohydrate of (1-{9-[4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-aminopurin-2-yl}pyrazol-4-yl)-N-methylcarboxamide
|
Filed: 2011-12-21
Issued: 2013-09-03
|
Active (5.1 yrs remaining)
Expires: 2031-12-21
|
|
|
US8106183
Process for preparing an A2A-adenosine receptor agonist and its polymorphs
|
Filed: 2010-04-22
Issued: 2012-01-31
|
Active (3.4 yrs remaining)
Expires: 2030-04-22
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.
High PTA (+1024 days) / In re Cellect scrutiny applies.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
4
Dispositive
4
Granted
0
Denied
0
Pending / Review
4
Motions by Category
Key Dispositive Motions & Rulings